The stock's fall snapped a two-day winning streak.

These were among the concerns of a recent regulatory inspection of a key, but historically troubled, manufacturing plant that ...

Whether it’s a cook, a home health aide, or a direct support professional, domestic workers are critical for so many people ...

U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...

The FDA has identified critical lapses at a production facility operated by Novo Nordisk that is used by several drugmakers, ...

Regeneron Pharmaceuticals faced a setback as the FDA postponed its decision on EYLEA HD's approvals to late 2025. This delay ...

"This is the first reported case of successfully using targeted therapy to treat a CAR-positive T-cell lymphoma," noted ...

Johnson & Johnson said on Thursday it would invest $2 billion in North Carolina as it aims to expand its U.S. manufacturing ...

A hedge fund run by legendary investor Michael Burry kicked off a new $383 million bullish bet split between four different ...

The company will be heavily investing over the next decade to build a new biopharmaceutical facility in Holly Springs, NC, ...